RKDA earnings

-- Zola® year-to-date revenues increase 26% year over year ---- Arcadia gross profit margins exceed 30% for 11th straight quarter ---- Arcadia cash balance declines by only $257K to $1.1M -- DALLAS, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the third quarter of 2025. "We are very pleased with our performance for the third quarter of 2025." said T.J. Schaefer, CEO of Arcadia. "Zola® coconut water revenues were flat year-over-year in the third quarter as we overlapped the initial sell-in to Zola's largest customer during the third quarter of 2024

-- Arcadia revenues increase 11% year over year driven by 24% growth in Zola® -- -- Arcadia receives 2.7 million shares of stock in ABVE -- -- Arcadia eliminates $1M in liabilities -- DALLAS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the second quarter and first half of 2025. "We are very pleased with our performance for the second quarter of 2025," said T.J. Schaefer, CEO of Arcadia. "While our total revenues have increased 11% compared to the second quarter of 2024, Zola® coconut water revenues have grown 24% and once aga

-- Revenues increase 22% year over year driven by 90% growth in Zola® ---- Arcadia sells patents for $750K and eliminates $1M in liabilities ---- Roosevelt agreement amended to provide greater certainty regarding exchange ratio -- DALLAS, May 08, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the first quarter of 2025. The company has scheduled a conference call at 2:00 p.m. Eastern time (11:00 a.m. Pacific time) to discuss first-quarter results and key strategic achievements. "The momentum we experienced in the second half of 2024 has

DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2025 on May 8, 2025. The company has scheduled a conference call for 2:00 p.m. Eastern time (11:00 a.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website.To join the live call, please register

-- Year-over-year revenues grew 56% in Q4 and 13% for full year -- -- Zola® year-over-year revenues increased 124% in Q4 and 46% for full year -- -- Company plans business combination with Roosevelt Resources, Inc. -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2024. "We are extremely pleased with the progress we made in 2024, particularly in the second half of the year following the sale of our GoodWheat™ assets," said T.J. Schaefer, president and CEO. "Our focus on Zola® coconut water led to 80 percent revenue growth f

Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the fourth quarter and full year of 2024 after market close on March 20, 2025. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss fourth-quarter and year-end results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, pleas

-- Companies to host a joint investor call on December 11, 2024 at 4:30 p.m. ET -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA) and Roosevelt Resources LP announced today that they have entered into a definitive securities exchange agreement which, when completed, will combine the two companies in an all-stock transaction. Under the terms of the agreement, Arcadia will issue to the partners of Roosevelt shares of Arcadia common stock at the closing of the transaction in exchange for all of the equity interests in Roosevelt. Following the closing of the transaction, the current equity owners of Roosevelt and the Arcadia shareholders as of the closing are expected to own approximately 90% and 1

– Total revenues increased 18% compared to Q3 2023 – – Zola® coconut water revenues grew 55% year over year – – Zola retail distribution expanded 68% vs. Q3 2023 – Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter and first nine months of 2024. "We are extremely pleased with our third-quarter 2024 results, which represent the progress we have made in transforming Arcadia's business as well as our ability to execute on the plan we laid out," said T.J. Schaefer, Arcadia's president and CEO. "Our total revenues increased 18 percent year over y

Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter of 2024 after market close on November 12, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss third-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, please register here, and a dia

-- Company closes $4M transaction with Corteva Agriscience -- -- Above Food Corp acquires GoodWheatTM brand -- -- Zola® coconut water sales increase 42% year over year -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the second quarter and first half of 2024. "The second quarter of 2024 was a significant turning point for Arcadia as we transform the business and chart our path to becoming cash flow positive," said T.J. Schaefer, president and CEO. "We monetized our wheat IP through two transactions: selling our resistant starch wheat trait to a wholly ow

Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2024 after market close on August 13, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss second-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, please regist

Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will host a call for analysts and investors after market close on May 22, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss recent strategic transactions. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available in the Investors section of Arcadia's website. To join the live call, please register here, and a dial-in number and unique PIN will be provided. Following completion of the cal

– Revenues increase sequentially and year-over-year – – Loss from continuing operations is at lowest level in 6 years – Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the first quarter of 2024. "Arcadia continued its positive trajectory in the first quarter of 2024," said Stan Jacot, president and CEO. "Revenue continues to grow, both sequentially and year-over-year, and we have transitioned the topline to high-quality revenue that generates gross profit across multiple sources. Operating expenses continued to decline at a double-digit pace versus last year

Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2024 after market close on May 9, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the conference call using the following numbers: U.S. Toll-Free Dial-In: +1 (888) 672-2415 International Dial-In: +1 (646) 307-1952 Passcode: 1615939 A live webcast of the conference call will be available on the Investors section of Arcad

-- Second continuous year of gross profit growth -- -- Total SG&A expenses declined to the lowest levels since 2019 -- -- GoodWheatTM now in more than 3,500 stores with better-for-you pasta, pancake/waffle mixes and mac & cheese -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2023. "We are now at the halfway point of Project Greenfield, our three-year strategic plan to unlock the company's potential and provide a path to profitability, and the results of this focus are unmistakable," said Stan Jacot, president and CEO

Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the fourth quarter and full year of 2023 after market close on March 28, 2024. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss fourth-quarter and year-end results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, pl

-- Increased revenue from continuing operations 20% quarter over quarter -- -- Lowest SG&A expenses since 2019 -- -- GoodWheat™ expanding into third category with upcoming launch of Mac & Cheese -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter of 2023. "Arcadia continues to make excellent progress in executing Project Greenfield, our three-year strategic plan to unlock the company's potential and provide a path to profitability," said Stan Jacot, president and CEO. "GoodWheatTM pasta and pancake mixes and Zola® coconut water added more

Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter of 2023 after market close on November 9, 2023. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss third-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, please register here and a dia

GoodWheat™ expands into breakfast category with the launch of better-for-you pancake and waffle mixes Exiting Body Care to reduce OpEx, focus on Food & Beverage Exploring strategic opportunities to drive shareholder value Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the second quarter and first half of 2023. "Arcadia continues to make progress executing Project Greenfield, our three-year strategic plan to unlock the company's potential and provide a path to profitability," said Stan Jacot, president and CEO. "Both GoodWheat™ pasta and Zola® coconut

Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2023 after market close on August 10, 2023. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss second-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available, with a link posted in the Investors section of Arcadia's website. To join the live call, please registe

– Significant improvement in gross profit dollars compared to last year – – GoodWheat™ pasta named "Best New Product" by Retail Dietitians Business Alliance – Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the first quarter of 2023. "We continue to focus on growing high quality revenue streams, as we closely manage resources," said Stan Jacot, president and CEO. "And the impact of this focus is clearly seen in our Q1 results, with notable improvements in gross profit dollars and operating expenses compared to last year." The company is also supporting exp

Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2023 after market close on May 11, 2023. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available in the Investors section of Arcadia's website. To join the live call, please register here, and a dial-in number and unique

-- Total revenues increased 47% compared to prior year -- -- Total operating expenses declined 32% year-over-year -- -- GoodWheat™ pasta in over 1200 stores within 7 months of launch -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2022. "Arcadia has made tremendous progress over the last year," said Stan Jacot, president and CEO. "We've streamlined the business by exiting less profitable brands, and we're focused on the most compelling opportunities that will build long-term value for our shareholders. "As a result, we'v

Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its 2022 fourth-quarter and full-year financial and business results after market close on March 30, 2023. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss fourth-quarter and year-end results and the year's key strategic achievements. Interested participants can join the conference call using the following options: An audio-only webcast of the conference call will be available in the Investors section of Arcadia's website. To join the live call, please register here, and

-- GoodWheat™ Pasta distribution doubles from Q2 ---- Gross margins improve to 28% ---- Streamlined operations focus on higher-margin brands --  DAVIS, Calif., Nov. 10, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter of 2022. "We've made significant progress this year transitioning Arcadia to a leaner, more focused organization," said Stan Jacot, president and CEO of Arcadia Biosciences. "And we continue to lay

DAVIS, Calif., Oct. 27, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter and first nine months of 2022 after market close on November 10, 2022. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss third quarter results and key strategic achievements. Interested participants can join the conference call using the following numbers: U.S. To

– Revenue increased 175% from Q2 2021 – – GoodWheat™ pasta successfully launched in retail and online – – $2M milestone achievement recognized for HB4® soybean approval in China – DAVIS, Calif., Aug. 11, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the second quarter and first half of 2022. "We're thrilled with this record-breaking quarter, but we are just getting started," said Stan Jacot, president and CEO of Arcadia Bioscie

DAVIS, Calif., July 28, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2022 after market close on August 11, 2022. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss second quarter results and key strategic achievements. Interested participants can join the conference call using the following numbers: U.S. Toll-Free

–  Sales increased 48% from Q4 2021 – – First retail orders of GoodWheat™ pasta shipped – – HB4® soybeans approved in China, $2M milestone anticipated – DAVIS, Calif., May 12, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the first quarter of 2022. "Arcadia is starting to see the fruits of all its labor over the last year as we transitioned to a CPG-driven company and right-sized the organization," said Stan Jacot, president an

DAVIS, Calif., May 5, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2022 after market close on May 12, 2022. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss first-quarter results and key strategic achievements. Interested participants can join the conference call using the following numbers: U.S. Toll-Free Dial-In:       +1-866

– Strong balance sheet entering 2022 – – Expanded consumer product offerings in on-trend categories – – Experienced CPG talent added throughout organization – DAVIS, Calif., March 30, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the fourth quarter and full year of 2021. "Arcadia had an unprecedented year of transition and entered consumer-focused categories for the first time" said Stan Jacot, president and CEO of Arcadia Bios

DAVIS, Calif., March 23, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its 2021 fourth-quarter and full-year financial and business results after market close on March 30, 2022. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss fourth-quarter and year-end results and the year's key strategic achievements. Interested participants can join the conference call using the following numbers: U.

DAVIS, Calif., Nov. 15, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter of 2021. "Our third quarter was a continuation of the exciting momentum Arcadia has generated since the beginning of the year, as we again produced strong financial results that further validate our successful transformation into a consumer products company," said Matt Plavan, CEO of Arcadia. "The quarter also was marked by a heightened inte

DAVIS, Calif., Nov. 8, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter and first nine months of 2021 after market close on November 15, 2021. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss third-quarter results and key strategic achievements. Interested participants can join the conference call using the following numbers: U.S. Tol

Achieves Q2 Net Sales of $54.2 Million Maintains Industry-Leading Balance Sheet with $257.5 Million in Cash NEO Accepts Normal Course Issuer Bid for Common Shares and Warrants up to $25M Expands Consumer Reach to over 70% of California and Acquires Additional Consumer Delivery Hub in Sacramento, California Conference Call to be Held Today, August 16, 2021, at 5:00 p.m. EDT  SAN JOSE, Calif., Aug. 16, 2021 /CNW/ - TPCO Holding Corp. ("The Parent Company" or the "Company") (NEO: GRAM.U) (OTCQX:GRAMF), today reported financial results for the second quarter ending June 30, 2021 ("Q2 2021"). All amounts are expressed in U.S. dollars. Q2 2021 Financial Highlights Net sales for Q2 2021 were $

DAVIS, Calif., Aug. 16, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the second quarter and first half of 2021. "In addition to being marked by five-fold revenue growth, our second quarter was the first time Arcadia recorded sales from our consumer brands, representing a key milestone in our transformation to a dynamic producer and marketer of innovative, plant-based health and wellness products," said Matt Plavan, CEO of Arca

DAVIS, Calif., Aug. 9, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half 2021 after market close on August 16, 2021. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss second-quarter results and key strategic achievements. Interested participants can join the conference call using the following numbers: U.S. Toll-Free Dia